...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Development of a Diagnostic Questionnaire for Damp Phlegm Pattern and Blood Stasis Pattern in Coronary Heart Disease Patients (CHD-DPBSPQ)
【24h】

Development of a Diagnostic Questionnaire for Damp Phlegm Pattern and Blood Stasis Pattern in Coronary Heart Disease Patients (CHD-DPBSPQ)

机译:冠心病患者抑制痰湿模式和血瘀模式的诊断调查(CHD-DPBSPQ)

获取原文

摘要

Background. The aim was to develop a diagnostic questionnaire for damp phlegm pattern and blood stasis pattern in coronary heart disease patients (CHD-DPBSPQ). Methods. The standard procedures of questionnaire development were carried out to develop and assess CHD-DPBSPQ. The patients were assessed using the CHD-DPBSPQ, CHD-DPPQ, and CHD-BSPQ. Four methods were used to select the items on the CHD-DPBSPQ in a pilot study based on data from a Guizhou tertiary grade A hospital. Cronbach’s alpha and the split-half reliability, test-retest reliability, content validity, criterion validity, construct validity, and convergent validity were determined in a validation study using a nationwide sample. Results. After item selection, the CHD-DPBSPQ contained 15 items in two domains: the phlegm domain (9 items) and the blood stasis domain (6 items). For the CHD-DPBSPQ, the alpha coefficient was 0.88, the split-half coefficient was 0.90, and the intraclass correlation coefficient was 0.83. The range of the item-level content validity index (I-CVI) was 0.71 to 1.0 and that of the scale-level content validity index/average (Scale-CVI/Ave) was 0.97. The domain scores on the CHD-DPBSPQ were in close relation to the scores on a questionnaire for damp phlegm pattern in coronary heart disease patients (CHD-DPPQ) and a questionnaire for blood stasis pattern in coronary heart disease patient (CHD-BSPQ) (P0.01). The root mean square error of approximation (RMSEA) was equal to 0.05 (90% CI: 0.044, 0.059). Convergent validity was demonstrated with a moderate correlation. Conclusion. The CHD-DPBSPQ is a reliable and valid instrument.
机译:背景。目的是在冠心病患者(CHD-DPBSPQ)中开发抑制抑菌模式和血瘀模式的诊断问卷。方法。开发和评估CHD-DPBSPQ的问卷发展的标准程序。使用CHD-DPBSPQ,CHD-DPPQ和CHD-BSPQ评估患者。基于来自贵州三级级医院的数据,使用四种方法在试验研究中选择CHD-DPBSPQ中的项目。 Cronbach的alpha和分裂半可靠性,测试 - 重新测试可靠性,内容有效性,标准有效性,结构有效性,构建有效性和收敛有效性在使用全国范围的样本中确定。结果。在项目选择之后,CHD-DPBSPQ包含两个域中的15个项目:Phlegm域(9项)和血液屏幕域(6项)。对于CHD-DPBSPQ,α系数为0.88,分裂半部系数为0.90,并且腹部相关系数为0.83。物品级内容有效性索引(I-CVI)的范围为0.71至1.0,尺度级内容有效性指数/平均值(Scale-CVI / AVE)为0.97。 CHD-DPBSPQ上的域名分数与冠心病患者(CHD-DPPQ)(CHD-DPPQ)(CHD-DPPQ)的潮湿痰湿调查表上的分数密切相关,以及冠心病患者(CHD-BSPQ)的血瘀模式调查问卷( P <0.01)。近似(RMSEA)的根均方误差等于0.05(90%CI:0.044,0.059)。通过中等相关性证明了会聚有效性。结论。 CHD-DPBSPQ是可靠且有效的仪器。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号